RD

Active Director Director DIN 07856904
DIN 07856904 First appointment Jul 2017 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Ritu Devi

Data last updated:

Ritu Devi is a Director at Ophthapure Pharma Private Limited (since 2017). The company operates in Food And Beverages. Ophthapure Pharma Private Limited reported revenue of ₹13.9 Lakh (FY 2025).

DIN 07856904
Primary Designation Director
Industry Food And Beverages
First Appointment 12 Jul 2017
Oldest Company Age 9 yrs
Largest company Ophthapure Pharma Private Limited · ₹13.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ophthapure Pharma Private Limited U24304UP2017PTC094936
Director12 Jul 20172017₹13.9 Lakh (FY 2025)Active

Board colleagues of Ritu Devi

NameDINCompanyDesignation
Sanjeev Pandey07856905Ophthapure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ophthapure Pharma Private Limited
Premium access

Shareholding and investment profile for Ritu Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Devi

Ritu Devi currently holds 1 directorship: Ophthapure Pharma Private Limited (Director, since 12 Jul 2017, revenue ₹13.9 Lakh (FY 2025)).

Ritu Devi was first appointed on 12 Jul 2017 as Director at Ophthapure Pharma Private Limited.

The current boards of Ritu Devi's companies include Sanjeev Pandey (Ophthapure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available